COVID-19 Orthopedic Company Updates
The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to keep you abreast of ways that competitors and customers are reacting to COVID-19. Mar 24, 2020
COVID-19 Impact: Procedure Deferrals Will Lead to Revenue Declines
After consulting with a host of industry veterans and observers, our guidance recommends that you expect and plan for business disruptions and revenue declines across the board—all companies, all market segments. Mar 20, 2020
Renovos to Develop Next-Gen Technology to “Tame” BMP-2 Diffusion
Regenerative medicine is an emerging market with solutions to not only heal but also grow tissue and bone. Renovos is addressing the issue of biological molecule diffusion through a synthetic nanoclay gel technology platform called Renovite. Mar 18, 2020
Enabling Technology is Here to Stay
The “wait and see” period for enabling technology in orthopedics is over. Commentary from executives and spending patterns of the largest orthopedic companies affirmed that message in the first three months of 2020. Mar 17, 2020
SI-BONE Double Digit Growth Fueled by Reimbursement Wins
Driven by additional favorable reimbursement decisions from payers and an expanding sales force, SI-BONE grew 22% in 2019. Mar 12, 2020
Orthopediatrics On Fast Track To $100 Million With Double Digit Growth
Expansion of its sales force and portfolio drove Orthopediatrics to 26% growth in 2019 as it climbs toward the $100 million annual revenue threshold. Mar 09, 2020
ATEC Outperforms Expectations With 24% Growth In 2019
With 12 new product launches and improvement across all major growth metrics, ATEC drove 24% growth in 2019 as it continues to reinvent itself. Mar 09, 2020
Conformis Growth Hamstrung by Aetna Denials in 2019
Unable to offset the loss of Aetna coverage and the lack of a cementless knee, Conformis sales declined in the low double-digits in 2019. Mar 04, 2020
Vericel’s High Growth Trajectory Has Staying Power
The company's MACI product drive 35% growth in 2019 and has penetrated just a quarter of Vericel's target addressable market of 5,000 surgeons. Feb 27, 2020
Orthofix’s Growth Slows as It Struggles to Fill Leadership Roles
Continuing vacancies in key leadership and commercial channel restructuring caused uncertainty and slower sales for Orthofix in 2019. Feb 26, 2020
